Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance

scientific article published on 9 December 2017

Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/21691401.2017.1411933
P698PubMed publication ID29226729

P50authorMohammed Asadullah JahangirQ92620570
P2093author name stringRuqaiyah Khan
Syed Sarim Imam
P2860cites workPharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjectsQ28252893
Modeling and comparison of dissolution profilesQ34215811
Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic studyQ35909694
Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approachQ35981175
Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspectsQ36044377
Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluationQ36442159
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.Q36733054
Formulation, optimization and evaluation of transferosomal gel for transdermal insulin deliveryQ42187215
The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in ratsQ43077401
Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteersQ43255836
In vitro and preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesicQ44333618
Methylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterizationQ45754039
Simultaneous determination of sitagliptin and metformin in their pharmaceutical formulation.Q45891140
Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodologyQ46861310
Morphological and physicochemical evaluation of the propranolol HCl-Eudragit® RS100 electrosprayed nanoformulations.Q48014962
Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic AnalysesQ48497592
Ultrasonically tailored, chemically engineered and "QbD" enabled fabrication of agomelatine nanoemulsion; optimization, characterization, ex-vivo permeation and stability studyQ50018916
Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: Application of factorial design approachQ50051554
Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: In-vitro characterization, and in-vivo appraisal.Q50657132
Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.Q51720618
Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study.Q51756206
Anal fissure nanocarrier of lercanidipine for enhanced transdermal delivery: formulation optimization, ex vivo and in vivo assessment.Q51761488
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.Q51820933
Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems.Q53286609
Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.Q53603608
In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.Q54587412
Design and formulation of mucoadhesive microspheres of sitagliptinQ56035517
Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluationQ57115503
P433issuesup1
P304page(s)66-78
P577publication date2017-12-09
P1433published inArtificial cells, nanomedicine, and biotechnologyQ27724536
P1476titleFormulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance
P478volume46